{
    "code": "02025071",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025071",
    "time": "2023-01-20 03:50:23",
    "許可證字號": "衛署藥輸字第025071號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/08\/17",
    "發證日期": "98\/08\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202507101",
    "中文品名": "“義大利”得舒緩膜衣錠 150 毫克",
    "英文品名": "Tarceva Film-coated tablets 150mg“Italy”",
    "適應症": "適用於具有EGFR-TK突變之局部侵犯性或轉移性之非小細胞肺癌(NSCLC)病患之第一線及維持治療。適用於先前已接受過化學治療後，但仍局部惡化或轉移之肺腺癌病患之第二線用藥。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ERLOTINIB HYDROCHLORIDE",
    "限制項目": "02輸　入 25監視中學名藥",
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FIT0463100  Delpharm Milano S.r.l.",
            "製造廠廠址": "Via Carnevale 1, 20054 Segrate (MI), Italy",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0093000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "GRENZACHERSTRASSE 124 CH-4070 BASEL,SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013001000",
            "成分名稱": "ERLOTINIB HYDROCHLORIDE",
            "含量描述": "(equivalent to Erlotinib 150 mg)",
            "含量": "163.9300000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tarceva ex Delpharm_CDS 18.0_1222-TAR-01_Del zip code change(700x470mm)_排-111-12-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025071&Seq=011&Type=9"
        },
        {
            "title": "150 mg_PI-110-03-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025071&Seq=010&Type=9"
        },
        {
            "title": "150 mg_FB-110-03-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025071&Seq=004&Type=8"
        },
        {
            "title": "150 mg_Blister-110-03-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025071&Seq=003&Type=8"
        },
        {
            "title": "20210319192101175-110-03-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025071&Seq=002&Type=8"
        }
    ]
}